Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price rose 11.7% during trading on Wednesday . The company traded as high as $35.66 and last traded at $35.54. Approximately 1,205,110 shares were traded during trading, a decline of 67% from the average daily volume of 3,677,894 shares. The stock had previously closed at $31.83.
Analysts Set New Price Targets
TEM has been the subject of a number of recent research reports. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They set a "buy" rating and a $74.00 price objective for the company. Bank of America lifted their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research report on Friday, December 13th. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and lifted their price objective for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reiterated a "neutral" rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Wolfe Research started coverage on Tempus AI in a research note on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $56.36.
Check Out Our Latest Research Report on TEM
Tempus AI Trading Up 9.7 %
The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a 50 day moving average price of $47.68 and a two-hundred day moving average price of $47.26.
Insider Activity
In related news, Director David R. Epstein sold 620 shares of the firm's stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $41.81, for a total transaction of $25,922.20. Following the sale, the director now directly owns 27,894 shares in the company, valued at approximately $1,166,248.14. This trade represents a 2.17 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the firm's stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the sale, the insider now owns 16,164,449 shares in the company, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 865,041 shares of company stock valued at $35,917,673 in the last three months.
Institutional Investors Weigh In On Tempus AI
Several hedge funds have recently modified their holdings of the stock. Avanza Fonder AB purchased a new stake in shares of Tempus AI during the 4th quarter valued at about $1,197,000. Bouvel Investment Partners LLC purchased a new stake in shares of Tempus AI during the 4th quarter valued at about $1,029,000. FNY Investment Advisers LLC purchased a new stake in shares of Tempus AI during the 4th quarter valued at about $67,000. Green Alpha Advisors LLC purchased a new stake in shares of Tempus AI during the 4th quarter valued at about $1,090,000. Finally, Silverleafe Capital Partners LLC purchased a new stake in shares of Tempus AI during the 4th quarter valued at about $533,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
